{"entity":{"id":"nct07133750","kind":"trial","name":"PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer","aka":[],"tldr":"A phase 2 trial of PM8002 in colorectal cancer, run by Biotheus Inc., now recruiting.","summary":"PM8002 (BNT327) in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer is a phase 2 interventional study registered as NCT07133750 by Biotheus Inc., with 100 participants planned, started 2025-08-19 and due to reach its primary completion in 2027-05. Interventions recorded: PM8002, Chemotherapy Regimen 1, Chemotherapy Regimen 2, Chemotherapy Regimen 3. Conditions listed: CRC (Colorectal Cancer). No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07133750","url":"https://clinicaltrials.gov/study/NCT07133750"}],"tags":["ctgov-ingest"],"related":[],"cancers":["colorectal"],"sections":[],"technologies":[],"targets":[],"drugs":["pm8002"],"companies":["biontech"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07133750","phase":"2","setting":"A Phase II, Multicenter, Open Label, Parallel Cohort Clinical Trial to Evaluate the Efficacy and Safety of PM8002 (BNT327) in Combination With Chemotherapy in First Line MSS or MSI-L/pMMR Metastatic Colorectal Cancer","sponsor":"Biotheus Inc.","enrolled":100,"outcomes":[]},"route":"/trials/nct07133750/","neighbours":{"cancer":[{"id":"colorectal","kind":"cancer","name":"Colorectal cancer","route":"/cancers/colorectal/"}],"drug":[{"id":"pm8002","kind":"drug","name":"PM8002","route":"/drugs/pm8002/"}],"company":[{"id":"biontech","kind":"company","name":"BioNTech","route":"/companies/biontech/"}]}}